Q4 2024 Earnings Call Transcript February 21, 2025 AdvanSix Inc. beats earnings expectations. Reported EPS is $0.01292, ...
Hello, and welcome to the AdvanSix fourth-quarter of 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to hand the call to Adam ...
为解决骨肉瘤治疗难题,武汉大学人民医院的研究人员开展 HMGCL 在骨肉瘤中作用的研究。结果发现 HMGCL 可抑制骨肉瘤进展,或为新治疗靶点。推荐科研读者阅读,助于了解骨肉瘤治疗新方向,开拓研究思路。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果